Independent LTC Pharmacy Advocacy Group Urges Stronger Effort on PDP Transparency in Response to CMS Draft 2017 Medicare Part D Call Letter

In response to the Centers for Medicare and Medicaid Service’s (CMS) draft 2017 Part D Call letter, the Senior Care Pharmacy Coalition (SCPC) urged still more rigorous efforts to ensure greater prescription drug plan (PDP) transparency in regard to Maximum Allowable Cost (MAC) pricing – despite a recent CMS initiative to do so…Read More

As Shkreli Puts Face on Drug Pricing Abuses, PBM Reimbursement Trends Analysis Prompts Long-Term Care Pharmacy Group to Call for Increased 2016 Congressional Investigation

Washington, DC — With former Turing Pharmaceuticals CEO Martin Shkreli significantly raising the public profile of prescription drug pricing abuses, the Senior Care Pharmacy Coalition (SCPC) is stepping up its criticism of anti-competitive pharmacy benefit manager (PBM) pricing practices by pointing to Avalere Health pharmacy data, which SCPC argues demonstrates PBMs’ pricing methodology leads to arbitrary and capricious reimbursement – warranting greater Congressional scrutiny and oversight in 2016…Read More

Senior Care Pharmacy Coalition (SCPC) Commends Oversight & Government Reform Committee Leaders for Examining Drug Pricing Practices

The Senior Care Pharmacy Coalition (SCPC) today commended House Oversight and Government Reform Committee Chairman Jason Chaffetz (R-UT) and Ranking Member Elijah Cummings (D-MD) for holding today’s hearing, “Developments in the Prescription Drug Market,” to examine exorbitant drug price increases and growing questions about abusive pharmacy benefit manager (PBM) pricing practices…Read More

PBMs Scrutinized for LTC Pharmacy Payment Practices

Pharmacy Times
Long-term care (LTC) pharmacies’ current prescription drug reimbursement model may not be sustainable, a new analysis suggests…Read More

Community, Long-Term Care Pharmacists Seek More Transparency From PBMs

Inside Health Policy
Community and long-term care pharmacists are pressing for more transparency in pharmacy benefit managers’ Maximum Allowable Cost lists that determine how much pharmacies are paid for generic drugs, pushing back against PBMs’ claims that transparency could lead to higher drug prices…Read More

New Avalere Health Study Reveals Substantial Variation in PDP/PBM Reimbursements for Most Commonly Prescribed Drugs in Long Term Care Settings

Washington, DC – Amid growing scrutiny of Pharmacy Benefit Manager (PBM) pricing practices, along with increasing concern from Congress, regulators and consumer groups about the rapid pace and broader implications of U.S. health sector mergers and consolidations, the Senior Care Pharmacy Coalition (SCPC) today released a new analysis of long term care (LTC) pharmacy transaction data…Read More

Senior Care Pharmacy Coalition Fighting for Drug Pricing Transparency

Pharmacy Podcast
Interview with Alan G. Rosenbloom, President and CEO of Senior Care Pharmacy Coalition (SCPC) about the Avalere Health Study: Long Term Care (LTC) Pharmacy Sector Plays Key, Growing Role in U.S. Seniors’ Care as New Payment, Delivery Models Gain Prevalence in the industry…Read More

New Avalere Health Study: Long Term Care (LTC) Pharmacy Sector Plays Key, Growing Role in U.S. Seniors’ Care as New Payment, Delivery Models Gain Prevalence

Major Structural, Regulatory and Legal Differences Between LTC and Retail Pharmacies Detailed; More Transparent Drug Pricing Can Help LTC Pharmacies Sustain High Quality SNF, ALF Patient Care Washington, DC – A new Avalere Health study of the nation’s growing long term care (LTC) pharmacy sector – the most detailed analysis since Medicare Part D was implemented read more…

Arkansas PBM Reform Law Targeting Generic Drug Pricing Abuses Good Model for Other States

Continuing the discussion surrounding the growing number of bipartisan state-based laws to reform secretive, opaque pricing policies practiced by the pharmacy benefit manager (PBM) industry, the Senior Care Pharmacy Coalition (SCPC) today praised Arkansas Gov. Asa Hutchinson (R-AR) for signing Act 900 into law earlier this year — ending PBMs’ ability to reimburse independent long-term care (LTC) pharmacies and others dramatically less than the actual cost of acquiring and dispensing generic drugs…Read More

State Efforts to Reform Secretive Pharmacy Benefit Manager (PBM) Pricing Policies Gain National Momentum

Roll Call
Americans today rightly demand more transparency in their governmental, financial and educational institutions. It is the foundation upon which to assess accountability, performance and trust…Read More

Twitter   LinkedIn